Umeclidinium Bromide
Who holds supplier records for Umeclidinium Bromide? 10 organisations hold a current record for Umeclidinium Bromide: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (3), Spain (1), Italy (1), Malta (1) and 1 other country (1); not recorded for 3.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Umeclidinium Bromide: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/umeclidinium-bromide
Reading the evidence
- 10 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (10)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Umeclidinium Bromide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Cipla LimitedIndia Company GMP cert on recordActive DMF 38002, 43534 · latest filing Mar 2026
- GLAXOSMITHKLINE LLCActive DMF 26339 · latest filing Nov 2012
- HIKMA PHARMACEUTICALS LLCActive DMF 35420 · latest filing Apr 2021
- INKE SASpainActive DMF 36482 · latest filing Jun 2023
- Lupin LimitedIndia Company GMP cert on recordActive DMF 38295 · latest filing Apr 2023
- MELODY HEALTHCARE PVT LTDIndiaActive DMF 38379 · latest filing May 2023
- OLON SPAItaly Company GMP cert on recordActive DMF 37680 · latest filing Mar 2023
- SHANDONG RISEN-SUN PHARMACEUTICAL CO LTDActive DMF 44238 · latest filing Jun 2026
- STERLING CHEMICAL MALTA LTDMalta Company GMP cert on recordActive DMF 39843 · latest filing Apr 2024
- TAPI NL BVNetherlandsActive DMF 32945 · latest filing Aug 2018
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Umeclidinium Bromide is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL523299).
Chemical identity
- IUPAC name
- diphenyl-[1-(2-phenylmethoxyethyl)-1-azoniabicyclo[2.2.2]octan-4-yl]methanol bromide
- Canonical SMILES
- C1C[N+]2(CCC1(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)CCOCC5=CC=CC=C5.[Br-]
- InChIKey
- PEJHHXHHNGORMP-UHFFFAOYSA-M
- Synonyms
- Anoro ellipta, Bromure d'umeclidinium, Bromuro de umeclidinio, GSK-573719A, GSK573719A, Incruse ellipta, Incruse ellipta (previously incruse), Rolufta ellipta (previously rolufta), Umeclidinium brom, Umeclidinium bromide, Umeclidinium bromide component of trelegy ellipta, C29H34BrNO2
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Anticholinergic
- Mechanism of action
- Cholinergic Antagonists
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Umeclidinium Bromide?
10 organisations hold an active US FDA Type II Drug Master File or a CEP for Umeclidinium Bromide: Cipla Limited (India), GLAXOSMITHKLINE LLC, HIKMA PHARMACEUTICALS LLC, INKE SA (Spain), Lupin Limited (India), MELODY HEALTHCARE PVT LTD (India), OLON SPA (Italy) and SHANDONG RISEN-SUN PHARMACEUTICAL CO LTD, and 2 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Umeclidinium Bromide Drug Master Files are active?
Cipla Limited (DMF 38002, 43534), GLAXOSMITHKLINE LLC (DMF 26339), HIKMA PHARMACEUTICALS LLC (DMF 35420), INKE SA (DMF 36482), Lupin Limited (DMF 38295), MELODY HEALTHCARE PVT LTD (DMF 38379), OLON SPA (DMF 37680) and SHANDONG RISEN-SUN PHARMACEUTICAL CO LTD (DMF 44238) and 2 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
How do I qualify a Umeclidinium Bromide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Umeclidinium Bromide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.